Intermediate-to-therapeutic versus prophylactic anticoagulation for coagulopathy in hospitalized COVID-19 patients: a systemic review and meta-analysis

BACKGROUND: Anticoagulation in hospitalized COVID-19 patients has been associated with survival benefit; however, the optimal anticoagulant strategy has not yet been defined. The objective of this meta-analysis was to investigate the effect of intermediate-to-therapeutic versus prophylactic anticoag...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Sirui, Li, Yupei, Liu, Guina, Su, Baihai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8611638/
https://www.ncbi.nlm.nih.gov/pubmed/34819094
http://dx.doi.org/10.1186/s12959-021-00343-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8611638/
https://www.ncbi.nlm.nih.gov/pubmed/34819094
http://dx.doi.org/10.1186/s12959-021-00343-1

Ejemplares similares